Discover 1,024 paid clinical trials in Saint Paul, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,024
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
for
Recurrent World Health Organization (WHO) Grade II Glioma,
Location: Minneapolis MN, Chicago IL, St Louis MO,
Sponsor: University of California, San Francisco
Sex: All
Age: 1 - 25
Code: NCT04485559
Phase 1, Recruiting
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
Location: Minneapolis MN, Chicago IL, St Louis MO,
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0+
Code: NCT01120353
Recruiting
Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
for
Medulloblastoma, Medulloblastoma, Childhood,
Location: Minneapolis MN, St Louis MO, Washington D.C. DC,
Sponsor: University of California, San Francisco
Sex: All
Age: 1 - 39
Code: NCT05057702
Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
for
Recurrent Langerhans Cell Histiocytosis,
Location: Minneapolis MN, Sioux Falls SD, Des Moines IA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 22
Code: NCT05828069
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
AERA Pediatrics Registry
for
Dysfunction of Eustachian Tube
Location: Minneapolis MN, West Bloomfield MI, Cincinnati OH,
Sponsor: Integra LifeSciences Corporation
Sex: All
Age: 0 - 18
Code: NCT07071298
Recruiting
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study
for
Hematopoietic and Lymphatic System Neoplasm,
Location: Minneapolis MN, Des Moines IA, Milwaukee WI, Omaha NE,
Sponsor: Children's Oncology Group
Sex: All
Age: 15 - 20
Code: NCT06410209
Phase 2, Recruiting
A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)
for
Von Willebrand Disease (VWD)
Location: Minneapolis MN, Iowa City IA, Peoria IL,